Amkor Technology
AMKR
$39.05
-10.70%
Amkor Technology is the world's largest pure-play outsourced semiconductor assembly and test (OSAT) provider, packaging and testing integrated circuits for semiconductor companies, foundries, and electronics OEMs across two product lines: Advanced Products (flip chip, wafer-level processing, advanced SiPs, power modules) and Mainstream Products (wirebond packaging and test), with the majority of revenue generated outside the United States. As a critical back-end manufacturing partner rather than a chip designer, Amkor occupies a strategically vital but historically low-multiple niche in the semiconductor value chain, competing against TSMC and Intel's internal packaging operations while benefiting from the industry-wide shift toward outsourced advanced packaging. The current investor narrative is dominated by the AI/HPC packaging boom — record Q2 2026 results with revenue up 25.6% year-over-year and a headline-grabbing strategic partnership with TSMC sent shares to a 52-week high near $96 in June 2026 — but the stock has since collapsed roughly 57% from that peak as investors question whether the AI-driven capacity expansion can sustain margins against rising competition and heavy capital spending. The debate now centers on whether the selloff is an overreaction to cyclical noise or a rational repricing of a capital-intensive business whose peak-cycle earnings may not be durable.…
AMKR
Amkor Technology
$39.05
Related headlines
Investment Opinion: Should I buy AMKR Today?
Rating: Hold. The core thesis is that Amkor's fundamentals remain genuinely strong — 25.6% revenue growth, gross margin expansion to 16.79%, and a forward PE of 14.90x — but the technical collapse (-55.3% max drawdown, -36.25 point three-month relative underperformance) and the risk that peak-cycle estimates get cut argue against catching the falling knife today. The analyst consensus leans bullish on price with an average target of $76.40 (+82.7% upside) but neutral on ratings, with Morgan Stanley, Goldman Sachs, and B. Riley all on the sidelines.
Supporting evidence for patience rather than purchase: the forward PE of 14.90x versus trailing 26.15x implies earnings must nearly double, a 43% multiple compression that is the entire bull case in one number. Revenue grew 25.58% year-over-year in Q2 2026 with Advanced Products at 82% of the mix, gross margin climbed from 12.04% to 16.79%, and TTM FCF of $516 million yields roughly 5.3% against the market cap. Against semiconductor norms, PS of 1.45x and EV/EBITDA of 8.56x are modest, but the PEG of 5.38x and 13.99% TTM gross margin justify part of the discount given the low-margin OSAT model.
Biggest risks that could invalidate the thesis: (1) forward EPS estimates being cut if AI packaging demand crests, collapsing the 14.90x forward PE illusion; (2) capex of $225 million per quarter consuming operating cash flow, leaving FCF volatile and negative in expansion quarters; (3) competitive pressure from TSMC and Intel compressing pricing. This Hold would upgrade to Buy if the stock stabilizes above the $50-56 September consolidation zone with gross margins holding above 16%, or downgrade to Sell if revenue growth decelerates below 15% or the stock breaks below $41 toward the $29.50 low. Valuation verdict: fairly valued to modestly undervalued on forward earnings, but expensive on PEG and vulnerable to estimate cuts — the market has de-rated substantially but not yet confirmed a bottom.
Sign up to view all
AMKR 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Amkor Technology's 12-month outlook, with a consensus price target around $74.50 and implied upside of +90.8% versus the current price.
Average Target
$74.50
0 analysts
Implied Upside
+90.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$46 - $92
Analyst target range
Coverage is moderate with 10 analysts, and the consensus is cautiously constructive despite the price collapse: the average target price of $76.40 implies +82.7% upside from the current $41.82, a gap so wide it signals either a major mispricing or stale estimates that have not yet caught up to the July-October drawdown. The recommendation field is listed as "none," but the institutional ratings history shows a mixed-to-positive tilt — Needham maintains Buy, UBS upgraded from Neutral to Buy on July 24, 2026, while Morgan Stanley (Equal Weight), Goldman Sachs (Neutral), and B. Riley (Neutral) remain on the sidelines. The consensus leans bullish on price targets but neutral on ratings, a combination that typically reflects analysts anchoring to pre-selloff fundamentals.
The target range of $65.00 to $92.00 is extremely wide — a 41.5% spread from low to high — signaling high uncertainty about the AI packaging cycle's durability. The $92 high target assumes the TSMC partnership scales, advanced packaging demand sustains 25%+ growth, and margins hold near Q2 2026 peaks, implying multiple expansion back toward the June highs; the $65 low target — still 55% above the current price — prices in margin compression and competitive pressure from TSMC and Intel but not a full cyclical downturn. Notably, even the lowest analyst target sits far above the current $41.82, which suggests the market has moved well ahead of published estimates and that downgrades or target cuts are a live risk; the recent pattern of reiterated Neutral/Equal Weight ratings alongside a UBS upgrade indicates analysts are divided, and the wide dispersion means position sizing should account for the possibility that the true downside case (a return toward the $29.50 52-week low) is not represented in any published target.
Bulls vs Bears: AMKR Investment Factors
The bear case currently has stronger near-term evidence: a 55.3% drawdown, -36.25 point three-month relative underperformance versus SPY, and a falling-knife technical structure with the stock at only 25.9% of its 52-week range. The bull case rests on fundamentals that remain genuinely strong — 25.6% revenue growth, gross margin expansion from 12.04% to 16.79%, and a forward PE of 14.90x that looks cheap if estimates hold. The single most important tension is whether Q2 2026's peak-cycle margins and the aggressive forward earnings implied by the 26.15x-to-14.90x PE compression are durable, or whether AI packaging demand is cresting as the sequential revenue flattening from Q4 2025 to Q2 2026 suggests. If forward estimates are met, the stock is materially undervalued; if they are cut, the trailing multiple is an illusion built on peak-cycle earnings.
Bullish
- Forward PE of 14.9x implies cheapness: The trailing PE of 26.15x collapses to a forward PE of 14.90x, implying the market expects earnings to nearly double over the next twelve months. If Q2 2026's $0.70 quarterly EPS annualizes near $2.80, the stock at $41.82 is trading at roughly 15x forward earnings — a modest multiple for a company growing revenue 25.6% year-over-year.
- Revenue growth accelerating at 25.6% YoY: Q2 2026 revenue of $1.898 billion rose 25.58% versus $1.511 billion in Q2 2025, and Q1 2026 was up 27.5% year-over-year. The Advanced Products segment generated $1.557 billion (82% of revenue), confirming Amkor is directly levered to the AI/HPC packaging boom rather than legacy wirebond.
- Margins expanded sharply year-over-year: Gross margin improved to 16.79% in Q2 2026 from 12.04% a year earlier, operating margin reached 10.53% versus 6.08%, and net income jumped to $173.75 million (9.15% net margin) from $54.4 million (3.60%). The sequential gross margin climb from 14.19% in Q1 2026 shows operating leverage on higher utilization and richer advanced-packaging mix.
- Analyst targets imply 82.7% upside: The average target price of $76.40 across 10 analysts implies +82.7% upside from $41.82, and even the lowest target of $65.00 sits 55% above the current price. UBS upgraded to Buy on July 24, 2026, and Needham maintains Buy, suggesting institutional coverage sees the selloff as overdone relative to fundamentals.
Bearish
- Falling-knife downtrend, -55.3% drawdown: The stock has collapsed 56.7% from its $96.68 52-week high to $41.82, with a 55.3% maximum drawdown, and is down 33.56% over three months and 37.92% over six months. The most recent session alone shed 5.06% on elevated volume of ~2.97 million shares, confirming momentum remains decisively with sellers.
- Severe relative underperformance vs. SPY: AMKR trails SPY by 36.25 percentage points over three months and 45.40 points over six months, even as it outperforms on a 1-year basis (+17.23 points). This divergence — positive 1-year return but collapsing recent momentum — is a classic trend-reversal signal rather than a temporary pullback.
- Structurally thin margins, peak-cycle earnings: TTM gross margin of 13.99%, net margin of 5.57%, and operating margin of 6.97% reflect a low-margin contract manufacturing model with limited buffer. The PEG ratio of 5.38x warns that even the forward growth is not being delivered cheaply relative to its expected rate, and peak-cycle Q2 margins may not be durable.
- Capex consumes nearly all operating cash flow: Quarterly FCF is highly volatile — $461 million in Q2 2026 but -$79.5 million in Q1 2026 and -$77.9 million in Q3 2025 — because capex of $225 million per quarter runs against operating cash flow of just $236 million. If the cycle turns while spending commitments are locked in, cash generation deteriorates rapidly.
AMKR Technical Analysis
Amkor is in a severe, accelerating downtrend despite still showing a positive 32.76% one-year price change, a divergence that reflects a violent boom-bust cycle within the trailing twelve months. At $41.82, the stock sits just 18.6% above its 52-week low of $29.50 and 56.7% below its 52-week high of $96.68 — trading at only 25.9% of its 52-week range, deep in the lower quartile. This positioning signals a falling-knife dynamic rather than a value opportunity: the stock has surrendered nearly all of its 2026 gains (YTD -2.56%) and the momentum is clearly with sellers, with the 55.3% maximum drawdown confirming a full-blown bear phase from the June peak.
Short-term momentum is decisively negative and worsening: the stock is down 9.64% over the past month, 33.56% over three months, and 37.92% over six months, with the most recent session alone shedding 5.06% on elevated volume of roughly 2.97 million shares. The 1-month decline directly contradicts the still-positive 1-year return, a classic divergence that typically signals trend reversal rather than temporary pullback — the market is repricing the stock's growth premium. Relative strength confirms the underperformance: AMKR trails SPY by 10.86 percentage points over one month, 36.25 points over three months, and 45.40 points over six months, even as it outperforms on a 1-year basis (+17.23 points), underscoring how completely the momentum regime has flipped.
Key technical levels are stark: support rests at the 52-week low of $29.50, roughly 29.5% below the current price, while resistance sits at the $96.68 high — a level that now looks like a distant memory. A breakdown below the recent $41-42 area (the stock closed at $41.82, its lowest print in the dataset) would open the door toward the $29.50 low, while any stabilization would first need to reclaim the $50-56 zone where the September consolidation occurred. With a beta of 2.224, Amkor is more than twice as volatile as the S&P 500 — a 1% market move implies roughly a 2.2% move here — which demands materially smaller position sizing and wider stops; the 2.73 short ratio adds fuel to both directions, raising squeeze risk on any positive catalyst but also amplifying downside momentum.
Beta
2.22
2.22x market volatility
Max Drawdown
-58.3%
Largest decline past year
52-Week Range
$30-$97
Price range past year
Annual Return
+26.9%
Cumulative gain past year
| Period | AMKR Return | S&P 500 |
|---|---|---|
| 1m | -28.5% | -1.2% |
| 3m | -39.9% | +3.4% |
| 6m | -50.0% | +7.0% |
| 1y | +26.9% | +14.4% |
| ytd | -9.0% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AMKR Fundamental Analysis
Revenue is growing robustly at the top line but the trajectory is lumpy and cyclical: Q2 2026 revenue of $1.898 billion rose 25.58% year-over-year versus $1.511 billion in Q2 2025, and marked a sequential increase from Q1 2026's $1.685 billion (+12.7% QoQ). The multi-quarter trend shows strong acceleration through the AI packaging cycle — Q1 2026 revenue of $1.685 billion was up 27.5% from Q1 2025's $1.322 billion, and Q4 2025's $1.888 billion was up 15.9% from Q4 2024's $1.629 billion — but the sequential flattening from Q4 2025 to Q2 2026 ($1.888B to $1.898B) hints that the growth rate may be cresting. Segment data confirms the mix: Advanced Products generated $1.557 billion versus $341 million from Mainstream, meaning the AI/HPC-exposed advanced packaging line drives roughly 82% of revenue and is the sole engine of growth — a concentration risk if AI demand cools.
Profitability has expanded meaningfully but remains structurally thin for a manufacturer: Q2 2026 net income of $173.75 million on a 9.15% net margin compares favorably to Q2 2025's $54.4 million and 3.60% margin, while gross margin improved to 16.79% from 12.04% a year earlier and operating margin reached 10.53% versus 6.08%. The sequential margin progression is impressive — gross margin rose from 14.19% in Q1 2026 to 16.79% in Q2 2026, and from 16.66% in Q4 2025 — reflecting operating leverage on higher utilization and a richer advanced-packaging mix. However, the trailing twelve-month gross margin of 13.99% and net margin of 5.57% (per valuation data) highlight that this is a low-margin contract manufacturing model where even peak-cycle profitability leaves limited buffer, and the 6.97% TTM operating margin underscores how sensitive earnings are to volume and pricing.
Balance sheet health is solid but cash generation is uneven and capital-hungry: debt-to-equity stands at a conservative 0.35 with a current ratio of 2.27, and TTM free cash flow is $516 million against a $9.76 billion market cap (roughly 5.3% FCF yield). Yet quarterly FCF is highly volatile — $461 million in Q2 2026, -$79.5 million in Q1 2026, $212 million in Q4 2025, and -$77.9 million in Q3 2025 — because capital expenditure is running at $225 million per quarter (Q2 2026) against operating cash flow of just $236 million, leaving thin coverage. ROE of 8.36% and ROA of 4.62% are modest for a technology company, and with capex consuming nearly all operating cash flow in expansion quarters, Amkor remains dependent on its $1.74 billion cash balance and debt markets to fund the capacity buildout — a real risk if the cycle turns while spending commitments are locked in.
Quarterly Revenue
$1.9B
2026-06
Revenue YoY Growth
+25.6%
YoY Comparison
Gross Margin
16.8%
Latest Quarter
Free Cash Flow
$516039000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AMKR Overvalued?
Because Amkor is profitable (Q2 2026 net income of $173.75 million; TTM EPS of $0.038 per the key metrics, distorted by the trailing window), the PE ratio is the appropriate primary metric, and the picture is bifurcated: the trailing PE of 26.15x versus a forward PE of 14.90x implies the market expects earnings to nearly double over the next twelve months, a 43% compression in the multiple. That gap is the entire bull case in one number — if forward estimates are met, the stock is cheap; if the AI packaging cycle rolls over and estimates are cut, the trailing multiple is not the bargain it appears. The PEG ratio of 5.38x, however, warns that even the forward growth is not being delivered cheaply relative to its expected rate.
Against semiconductor industry norms, Amkor trades at a discount on most metrics: PS of 1.45x and EV/Sales of 1.49x are low for a semiconductor name, and EV/EBITDA of 8.56x is modest versus the sector's typical mid-teens to twenties for AI-exposed chip companies. The premium metrics are PB at 2.18x and PCF at 8.91x, while the 13.99% gross margin and 5.57% net margin are structurally below fabless designers and foundries — the discount is therefore partly justified by Amkor's low-margin OSAT model and capital intensity, though the 8.56x EV/EBITDA suggests the market is pricing in meaningful cyclical risk rather than paying for the AI growth story.
Historically, Amkor's valuation has compressed dramatically: the PE ratio stood at 30.80x in Q2 2026, 33.11x in Q1 2026, and 14.30x in Q4 2025, while PS was 11.25x in Q2 2026 versus 5.17x in Q4 2025 and 3.53x in Q3 2025 — showing the stock was priced for perfection at the June peak and has since mean-reverted hard. The current trailing PE of 26.15x sits in the middle of its multi-year band (which ranged from roughly 7x in 2022 to 52x in Q1 2025), while the 2.18x PB is near the low end of its historical 1.1x-4.6x range, suggesting the market has already de-rated the stock substantially — but with forward earnings expectations still aggressive, the risk is that the "cheap" multiple is an illusion built on peak-cycle estimates.
PE
26.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 3x~53x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on capital intensity and margin durability. Capex of $225 million per quarter against operating cash flow of just $236 million in Q2 2026 leaves thin coverage, and quarterly FCF swung from $461 million in Q2 2026 to -$79.5 million in Q1 2026. With TTM gross margin of 13.99% and net margin of 5.57%, even peak-cycle profitability leaves limited buffer, and 82% revenue concentration in Advanced Products means an AI demand cooldown would hit the sole growth engine directly. The sequential revenue flattening from $1.888 billion in Q4 2025 to $1.898 billion in Q2 2026 is an early warning that the growth rate may be cresting while spending commitments remain locked in.
Market and competitive risks are dominated by valuation compression and the TSMC/Intel competitive threat. The stock was priced for perfection at the June peak — PS of 11.25x in Q2 2026 versus 5.17x in Q4 2025 — and has mean-reverted hard to 1.45x, but with forward earnings expectations still aggressive, further de-rating is possible. Amkor competes against TSMC and Intel's internal packaging operations even as its TSMC partnership scales, and Zacks explicitly flags that competition from TSM and INTC looms over the AI/HPC packaging demand story. A beta of 2.224 means the stock moves roughly 2.2% for every 1% S&P move, amplifying any sector rotation out of semiconductors; the 2.73 short ratio adds fuel to downside momentum on negative catalysts.
Worst-case scenario: AI packaging orders decelerate, forward EPS estimates are cut, and the 14.90x forward PE proves illusory as the trailing multiple re-rates toward its 2022 low near 7x. In that chain, the stock breaks the $41-42 support area and retests the 52-week low of $29.50 — a loss of roughly 29.5% from the current $41.82. Notably, even the lowest published analyst target of $65.00 sits 55% above the current price, meaning the true downside case is not represented in any published target and the market has moved well ahead of estimates; a return toward $29.50 would represent a further -29.5% decline from here.
FAQ
Ranked by severity: first, estimate-cut risk — the entire bull case rests on the 14.90x forward PE, and if AI packaging demand crests (as the sequential revenue flattening from $1.888B to $1.898B hints), forward EPS gets cut and the cheap multiple becomes an illusion, with downside to the $29.50 low (-29.5%). Second, competitive risk — TSMC and Intel internal packaging operations loom over the AI/HPC story even as the TSMC partnership scales, threatening pricing and share in the 82%-of-revenue Advanced Products segment. Third, financial/capital-intensity risk — capex of $225 million per quarter against operating cash flow of $236 million leaves thin coverage, with FCF swinging from $461 million to -$79.5 million quarter to quarter. Fourth, macro/market risk — a beta of 2.224 means a 1% S&P decline implies roughly a 2.2% AMKR decline, and the 2.73 short ratio amplifies downside momentum on negative catalysts.
The three-scenario framework assigns 50% to the base case of $50-65, where AI packaging demand stays solid but growth decelerates from 25.6% toward the high-teens and margins settle below Q2's 16.79% peak, with the stock stabilizing in the September consolidation zone. The bull case (25% probability) targets $76-92 if the TSMC partnership scales and margins hold near peaks, validating the 14.90x forward PE and re-expanding the multiple toward the analyst average of $76.40. The bear case (25% probability) targets $29.50-42 if estimates are cut and the stock retests its 52-week low. The base case is most likely, and its key assumption is that revenue growth stays positive at 15-20% without a major AI demand shock — note that even the lowest analyst target of $65.00 sits 55% above the current price, so published estimates have not yet caught up to the drawdown.
The valuation is bifurcated. On trailing metrics the stock looks mid-range — PE of 26.15x sits in the middle of its multi-year band (roughly 7x in 2022 to 52x in Q1 2025), and PB of 2.18x is near the low end of its 1.1x-4.6x historical range. On forward earnings it looks cheap at 14.90x, but that requires earnings to nearly double, a 43% multiple compression the market has not yet validated. Against semiconductor peers, PS of 1.45x and EV/EBITDA of 8.56x are modest, though the 13.99% gross margin and 5.57% net margin justify part of the discount given the low-margin OSAT model. The PEG of 5.38x is the warning sign — the market is paying a fair-to-modest price on forward numbers but a rich one relative to the expected growth rate, implying it expects the AI packaging cycle to hold but is not willing to pay peak multiples for it.
From a risk/reward perspective, AMKR offers an asymmetric setup only if you believe forward estimates: the average analyst target of $76.40 implies +82.7% upside, and the forward PE of 14.90x versus trailing 26.15x means the market expects earnings to nearly double. But the downside is real — the stock is 56.7% below its $96.68 high with a 55.3% max drawdown, and a break below $41-42 support opens the door to the $29.50 low, roughly -29.5% from here. The PEG of 5.38x and 13.99% TTM gross margin mean you are not getting the growth cheaply, and the 2.224 beta amplifies every market move. It is a reasonable buy for risk-tolerant investors who size positions small and wait for stabilization above $50-56, but not for conservative portfolios or anyone unwilling to absorb another 30% drawdown.
AMKR is better suited to a medium-to-long-term holding with a minimum suggested horizon of 12-18 months, not short-term trading. The beta of 2.224 and 2.73 short ratio make short-term price action dominated by momentum and squeeze dynamics — the stock fell 5.06% in a single session and 33.56% over three months — which is hostile to tactical positioning. The dividend yield of just 0.84% with a 21.9% payout ratio provides minimal income support, so returns depend entirely on earnings delivery and multiple re-rating. Earnings visibility is moderate: Q2 2026 EPS of $0.70 annualizes near $2.80, but quarterly FCF volatility ($461 million to -$79.5 million) and capex commitments mean the cycle matters more than any single quarter. Long-term holders should anchor on the 5.3% FCF yield and 0.35 debt-to-equity as downside support while waiting for the AI packaging cycle to prove durable.